Wolff-Parkinson-White syndrome. Evaluation of a potentially life threatening situation.
D000328:Adult; D001281:Atrial Fibrillation / Q000188:drug therapy / Q000503:physiopathology; D004077:Digoxin / Q000009:adverse effects*; D004206:Disopyramide / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009943:Organophosphorus Compounds / Q000627:therapeutic use; D012032:Refractory Period, Electrophysiological / Q000187:drug effects; D014927:Wolff-Parkinson-White Syndrome / Q000188:drug therapy / Q000503:physiopathology*
D009943:Organophosphorus Compounds; D004077:Digoxin; D004206:Disopyramide